Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "US Gout Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
This latest research provides comprehensive insights into Gout pipeline products, Gout epidemiology, Gout market valuations and forecast, Gout drugs sales and competitive landscape in the US.
The research is classified into seven sections - Gout treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope
Benefits of this Research
Key Topics Covered
1) Gout Treatments
2) Gout Pipeline
3) US Gout Epidemiology
4) Marketed Drugs for Gout in US
5) US Gout Market Size and Forecast
6) US Gout Products Sales and Forecast
7) US Gout Market Competitive Landscape
8) Methodology
List of Tables
1. Gout Phase 3 Clinical Trials, 2019
2. Gout Phase 2 Clinical Trials, 2019
3. Gout Phase 1 Clinical Trials, 2019
4. Gout Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Gout, US, 2018
6. Gout Market Size and Forecast ($), US, 2014 - 2024
7. Gout Product Sales ($), US, 2014 - 2024
List of Figures
1. Gout Epidemiology, US, 2014 - 2024
2. Gout Market Size and Forecast ($), US, 2014 - 2024
3. Gout Products Market Share (%), US, 2018
For more information about this report visit https://www.researchandmarkets.com/r/yd55kn
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.